New COPD inhaler tested for Year-Long safety
NCT ID NCT07425210
First seen Feb 21, 2026 · Last updated May 13, 2026 · Updated 10 times
Summary
This study looks at the long-term safety of an experimental inhaled drug called HSK39004 for people with moderate-to-severe COPD. About 300 adults aged 40 to 80 will take the drug twice daily for 52 weeks. The goal is to monitor side effects and see if the drug remains safe over time. This is not a cure, but aims to help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guizhou Provincial People's Hospital
Guiyang, Guizhou, 550002, China
Conditions
Explore the condition pages connected to this study.